Clinical trial
A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Immune Function Disorders Using a Reduced Intensity Preparatory Regime
NCT01821781 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Immune Function Disorders Using a Reduced Intensity Preparatory Regime
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- April 29, 2013
- Completion date
- April 30, 2026
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune lymphoproliferative syndrome, chediak-higashi syndrome, chronic granulomatous disease, common variable immune deficiency, digeorge syndrome, hemophagocytic lymphohistiocytosis, hyper-igm, immune deficiency disorders, immune dysregulatory disorders, ipex, severe combined immunodeficiency, wiskott-aldrich syndrome, x-linked agammaglobulinemia, x-linked lymphoproliferative syndrome